Hestia Insight Inc. (HSTA)
Market Open
11 Aug, 20:00
OTC PINK OTC PINK Primary $
0. 03
0
0%
$
922K Market Cap
- P/E Ratio
- Div Yield
4,000 Volume
0 Eps
$ 0.03
Previous Close Want to track HSTA and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Summary
HSTA trading today higher at $0.03, an increase of 0% from yesterday's close, completing a monthly decrease of -32.6531% or -$0.02. Over the past 12 months, HSTA stock lost -17.5%.
HSTA is not paying dividends to its shareholders.
The last earnings report, released on Jun 01, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Hestia Insight Inc. has completed 1 stock splits, with the recent split occurring on May 09, 2019.
The company's stock is traded on one exchange.
Hestia Insight Inc. (HSTA) FAQ
What is the stock price today?
The current price is $0.03.
On which exchange is it traded?
Hestia Insight Inc. is listed on OTC PINK.
What is its stock symbol?
The ticker symbol is HSTA.
Does it pay dividends? What is the current yield?
It does not pay dividends to its shareholders.
What is its market cap?
As of today, the market cap is 922K.
Has Hestia Insight Inc. ever had a stock split?
Hestia Insight Inc. had 1 splits and the recent split was on May 09, 2019.
Hestia Insight Inc. Profile
| Software Industry | Information Technology Sector | Edward C. Lee CEO | OTC PINK Exchange | 42815H109 CUSIP |
| US Country | 3 Employees | - Last Dividend | 9 May 2019 Last Split | - IPO Date |
Overview
Hestia Insight Inc. operates in the sphere of strategic consulting and capital market advisory, specifically targeting micro, small, and medium-sized companies within the healthcare and biotech sectors. Its expertise extends to the development of healthcare technologies aimed at the treatment of neurological and psychiatric disorders. Initially known as Luxshmi Investments, Inc., it underwent a name change to Hestia Insight Inc. in May 2019. Founded in 2003, the company has established its base in Las Vegas, Nevada, leveraging its strategic location to provide a plethora of services ranging from medical supply sales and marketing support to comprehensive management and capital markets advisory services.
Products and Services
- Strategic Consulting and Capital Market Advisory Services: Specializing in the healthcare and biotech sectors, Hestia Insight Inc. offers bespoke consulting services aimed at enhancing the operational and financial efficiencies of micro, small, and medium-sized companies. These services are designed to navigate the complexities of the capital markets, providing companies with the insight and strategy needed to thrive.
- Healthcare Technology Development: Focusing on the development of cutting-edge technologies, Hestia Insight Inc. is committed to advancing treatment options for neurological and psychiatric disorders. This involves the research and creation of innovative solutions that have the potential to transform patient care in these areas.
- Medical Supply Sales and Marketing Support: Hestia Insight Inc. extends its expertise to the sales and marketing of medical supplies. This includes providing comprehensive support to companies within the healthcare sector, aiming to increase their market presence and ensuring the effective distribution of their products.
- Management and Capital Markets Advisory Services: With a broad range of management services, Hestia Insight Inc. offers guidance in capital markets advisory. This ensures that client companies are well-positioned to make informed decisions about their investments, financial strategies, and overall operational structure.
Contact Information
Address: 732 South
Phone: 702 793 4028
Website: https://www.hestiainsight.com
